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TRUCUT NEEDLE BIOPSY IN BREAST LUMPS
by
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Breast Clinic, The Ulster Hospital, Dundonald, Belfast
THE clinical differentiation between benign and malignant breast lumps is fraught
with danger. A small proportion of cases present with classical findings but in the
majority it is essential to have a histological or cytological diagnosis before surgery
is undertaken.
Trucut needle biopsy (TCN) ofsolid tumours is now established as a useful means
of obtaining representative biopsy material and has been used widely in liver and
kidney disease. However, its usefulness in the diagnosis of solid breast lumps
remains controversial. To evaluate the technique we carried out 250 consecutive
TCN biopsies and the results of the series are presented.
MATERIALS AND METHODS
Two hundred and forty-two women attending the Breast Clinic were subjected to
TCN. Some had simultaneous fine needle aspiration (FNA) and some went on to
have excision biopsy or mastectomy. Lumps smaller than 0.5 cm in diameter were
not suitable for biopsy due to difficulty in accurately locating the lump with the
trucut needle.
BIOPSY TECHNIQUE
The lump was steadied between the thumb and forefinger ofthe left hand and the
overlying skin infiltrated with one ml of two per cent lignocaine. A small (5 mm)
incision was made directly over the lump and the trucut needle (Travenol
Laboratories Inc) was introduced through the wound. The obturator was then thrust
into the lump and the sheath advanced, trapping tissue in the specimen notch. The
complete needle was then withdrawn and the specimen placed in ten per cent
buffered formalin. Pressure was applied to the wound for two to three minutes to
arrest haemorrhage, after which a pressure dressing was applied. A satisfactory
specimen was 1-2 cm long and up to 2 mm in diameter. If it was felt that the
specimen was inadequate a further biopsy could be taken through the same incision.
Once mastered, the procedure was usually painless, although five patients
experienced some mild discomfort. Two hundred and fifty TCN biopsies were
performed on solid tumours in 242 patients. When the biopsy was reported as
carcinoma and the clinical findings were in agreement, mastectomy was undertaken.
In biopsies reported as benign (fibroadenosis, fibroadenoma, etc), depending on the
degree ofclinical suspicion, either excision biopsy was undertaken or thepatient was
followed-up for a minimum period of six months to establish that the lump was
benign. In a number of cases fine needle aspiration (FNA) was undertaken
simultaneously and formed the basis of a previous report.'
RESULTS
The results are detailed in the Table. Of a total of 250 TCN, 40 specimens were
considered to be unsatisfactory or inadequate by the pathologist. One hundred and
five of the remaining 210 were reported as carcinoma and all of these were
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TCNcompared withfinal diagnosis
TCNDiagnosis Final Diagnosis
Benign Malignant
Unsatisfactory biopsies 40 28 12
Benign 94 89 5
Suspicious 11 2 9
Malignant 105 - 105
TOTAL 250 119 131
subsequently confirmed by the histology of the mastectomy specimen. Thirty-nine
ofthe 94 biopsies reported as benign disease had excisional biopsy and ofthese, five
werecarcinomas. Afurther 11 biopsieswere labelledas 'suspicious' and consequently
had excisional biopsies carried out, of which nine proved to be carcinoma. If these
are excluded there were five false negatives in 94 patients which is 5.3 per cent. There
were 74 patients who did not subsequently have an excisional biopsy. These have
been followed up and to date have shown no evidence of malignancy.
Twenty-oneofthe40 patientswho had unsatisfactoryTCN biopsies had excisional
biopsies because of suspicion of malignancy and 12 proved to be carcinomas.
During the study TCN biopsies were taken by both a consultant and a number of
junior doctors. Our figures show that both the consultant and thejunior doctors had
100 per cent accuracy with biopsies reported as being malignant. Of the 80 biopsies
performed by the consultant and the 62 performed by thejunior doctors reported as
not showing carcinoma, six (7.5 per cent) of the former and eight (12.9 per cent) of
the latter ultimately proved to be malignant. This is not a significant difference
(X2 0.62 d.f. = 1, 0.5)> p> 0.3).
DISCUSSION
Cancer of the breast is still responsible for the greatest number of deaths from
malignant disease in women and the incidence appears to be rising.2 Prognosis is
thought to be improved by early diagnosis3 and therefore any method which
contributes to this deserves due consideration. Also, more attention is now being
paid to the psychological complications which arise from breast disease and many
surgeons like to discuss the treatment with the patient before surgery. An excisional
biopsy has several main disadvantages: (1) it normally requires ageneral anaesthetic,
(2) the incision may affect the choice of incision for definitive surgery and (3) many
surgeons do not feel that frozen section examination of the biopsy should be
followed by immediate definitive surgery. These objections are largely overcome by
TCN biopsy. Furthermore, when excisional biopsy is carried out, most surgeons are
reluctant to send part of the specimen for oestrogen receptor assay in case that
portion contains the entire carcinoma, thus causing a false negative histology report.
Consequently, most lumps are sent in their entirety for histology. In the case of a
diagnosis obtained with TCN the remaining tissue can be sent for assay at definitive
surgery.
143It has been postulated that as with FNA accuracy should improve with
experience.4 Our figures suggest that this is not the case and the technique is equally
suitable for senior surgeons and those in training.
Concern has been expressed regarding the seeding ofthe needle track with tumour
cells. This has been investigated with regard to FNA by Robbins et al5who registered
the survival times of 1463 patients with- mammary carcinoma submitted to radical
surgery and compared the survival rates in patients who had FNA with those who
did not. They found that the two groups did not differ in their ten year survival rates
as long as the needle track was excised at mastectomy. Although FNA cannot
bestrictly equated with TCN, we feel that TCN is a safe procedure. We would also
stress that TCN is a simple technique which can easily be performed in a normal out-
patient clinic as no special facilities are required. Patient acceptance is high and
apart from mild bruising, no complications have been experienced. Confidence in
the technique has increased with experience and, provided it is used in conjunction
with clinicaljudgement, it is a safe, cheap and virtually painless method ofmaking a
reliable diagnosis. Sincewe have had no false positive results, we agree with Elston et
a16 that when TCN is reported as showing a carcinoma definitive surgery can be
undertaken with assurance. However, caution should be exercised with benign TCN
biopsies and in patients where there is the slightest doubt that the lump is benign,
excision biopsy should be undertaken.
In conclusion, we have found the technique of trucut needle biopsy useful in the
pre-operative diagnosis of solid breast lumps and advocate that the technique plays
an increasing role in the diagnosis and management of these patients.
SUMMARY
The technique of trucut needle biopsy (TCN) is described. Two hundred and fifty
consecutive TCN were performed in 242 women and 84 per cent of these provided
satisfactory biopsies. There were no false positive results. In 14 satisfactory biopsies
the diagnosis of carcinoma was not made and these were considered to be false
negative results. TCN was found to be a reliable means of pre-operative diagnosis
when the biopsy showed carcinoma, enabling mastectomy to be undertaken safely,
rendering excisional biopsy and frozen section unnecessary.
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